We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A federal judge in San Antonio Aug. 29 upheld a judgment in favor of devicemaker BlueSky Medical Group in a patent infringement suit brought against the firm by Kinetic Concepts (KCI) in 2003, said Randy McClanahan, the Houston-based attorney for BlueSky.
Mylan Technologies wants the FDA to hold off on approving pain patches until studies show that overlays to keep the devices stuck to the skin are safe.
CytoCore has announced that the company has secured $4 MM in new equity financing during the quarter ending June 30, 2006, as the organization has neared completion of its financial restructuring and prepared for clinical trials and manufacturing.
A rush of $4 million in financing is proof for the Halifax firm Medusa Medical Technologies that venture capital investors believe in the power of health technology to transform medicine.
NeuroMetrix, Inc., a medical device company focused on the development and sale of proprietary products that help physicians diagnose neuropathies, including carpal tunnel syndrome and diabetic peripheral neuropathy, announced that it has received an updated FDA 510(k) clearance for its NC-stat nerve conduction testing system.
Advanced Semiconductor Engineering (ASE) announced that it has been selected by Medtronic as its IC packaging and testing services partner for a range of devices used in medical applications, including for pacemaker and defibrillator devices.
Medical Corporation announced that it has received U.S. FDA 510K marketing clearance for a new vascular implant device called the iVENA Vascular Patch.
A district court Aug. 28 ruled in favor of Innogenetics NV, an international biopharmaceutical firm that is building a diagnostics business, in a patent dispute with Abbott Laboratories, Innogenetics said Aug. 29.